RABL3
Basic information
Region (hg38): 3:120684938-120742993
Links
Phenotypes
GenCC
Source:
- pancreatic cancer, susceptibility to, 5 (Limited), mode of inheritance: AD
- familial pancreatic carcinoma (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pancreatic cancer, susceptibility to, 5 | AD | Oncologic | Individuals are reported to be at increased risk of pancreatic cancer (as well as other neoplasms), and awareness may allow early diagnosis and management | Oncologic | 31406347 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RABL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 5 | 1 |
Variants in RABL3
This is a list of pathogenic ClinVar variants found in the RABL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-120689896-C-G | RABL3-related disorder | Benign (Jan 03, 2020) | ||
3-120694160-A-G | not specified | Uncertain significance (Aug 04, 2023) | ||
3-120694183-A-C | not specified | Uncertain significance (Oct 05, 2021) | ||
3-120694208-C-T | RABL3-related disorder | Likely benign (Aug 12, 2022) | ||
3-120698448-T-A | RABL3-related disorder | Likely benign (Jun 10, 2024) | ||
3-120698483-A-G | RABL3-related disorder | Likely benign (Jul 01, 2024) | ||
3-120698500-G-C | RABL3-related disorder | Uncertain significance (Oct 01, 2022) | ||
3-120698576-G-A | RABL3-related disorder | Likely benign (May 09, 2022) | ||
3-120706004-T-A | RABL3-related disorder | Uncertain significance (Sep 08, 2022) | ||
3-120706028-C-T | RABL3-related disorder | Uncertain significance (Oct 04, 2022) | ||
3-120706090-G-A | RABL3-related disorder | Uncertain significance (Apr 25, 2023) | ||
3-120706104-G-A | RABL3-related disorder | Likely benign (Dec 20, 2023) | ||
3-120709774-T-C | RABL3-related disorder | Benign (Nov 05, 2019) | ||
3-120709787-G-A | RABL3-related disorder | Likely benign (Jan 01, 2024) | ||
3-120709797-A-G | not specified | Uncertain significance (Aug 09, 2021) | ||
3-120709856-T-C | RABL3-related disorder | Likely benign (Dec 04, 2023) | ||
3-120730695-C-T | RABL3-related disorder | Uncertain significance (Dec 26, 2023) | ||
3-120730727-G-T | Pancreatic cancer, susceptibility to, 5 | risk factor (Nov 26, 2019) | ||
3-120730738-C-T | RABL3-related disorder | Likely benign (Mar 02, 2022) | ||
3-120730761-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
3-120742456-G-A | RABL3-related disorder | Likely benign (Feb 22, 2022) | ||
3-120742488-A-C | not specified | Uncertain significance (Sep 25, 2023) | ||
3-120742501-A-T | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RABL3 | protein_coding | protein_coding | ENST00000273375 | 8 | 56313 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000802 | 0.936 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.432 | 115 | 129 | 0.893 | 0.00000675 | 1530 |
Missense in Polyphen | 35 | 44.737 | 0.78236 | 535 | ||
Synonymous | -0.134 | 48 | 46.8 | 1.02 | 0.00000237 | 448 |
Loss of Function | 1.65 | 7 | 13.5 | 0.517 | 5.70e-7 | 177 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.511
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.642
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.925
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rabl3
- Phenotype
Gene ontology
- Biological process
- intracellular protein transport;Rab protein signal transduction
- Cellular component
- cell
- Molecular function
- GTPase activity;GTP binding